Literature DB >> 18636423

Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy.

Andrea F Patenaude1, Sara Orozco, Xiaochun Li, Carolyn M Kaelin, Michelle Gadd, Yvedt Matory, Kathleen Mayzel, Constance A Roche, Barbara L Smith, Walden Farkas, Judy E Garber.   

Abstract

OBJECTIVE: Prophylactic mastectomy (PM) offers 90% or greater reduction in risk of breast cancer to women at increased hereditary risk. Nonetheless, acceptance in North America is low (0-27%) and 25-50% of women electing surgery report psychological distress and/or difficulty adapting following PM. Most women also report reduced cancer worry postoperatively. Psychological consultation to aid decision-making and post-surgical coping is not routinely offered. This retrospective, cross-sectional study explored interest in and acceptability of psychological consultation for issues related to PM among 108 women who had undergone or were considering surgery.
METHOD: Qualitative interviews were conducted with 26 healthy women who had undergone prophylactic mastectomy of both (bilateral) breasts (BPM), 45 women who had undergone prophylactic mastectomy of one breast (unilateral contralateral) (UPM) after diagnosis of invasive breast cancer in the other breast or ductal carcinoma in situ (DCIS), and 37 women who were considering having PM surgery.
RESULTS: Of the women who had undergone PM, more than half felt pre-surgical psychological consultation was advisable; nearly 2/3 thought post-surgical psychological consultation would be helpful. All women currently considering PM believed psychological consultation would aid decision-making and preparation for surgery. Strong support was reported in all groups for the emotional and informational value of speaking with a woman who had previously undergone PM.
CONCLUSIONS: Narratives illustrate the nature and intensity of the need for psychological support and describe preferences for the role of the psychologist. Suggestions are offered for integration of psychological services for women deciding about or adapting to PM.

Entities:  

Mesh:

Year:  2008        PMID: 18636423      PMCID: PMC4133134          DOI: 10.1002/pon.1279

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  30 in total

1.  Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.

Authors:  M Dorval; A F Patenaude; K A Schneider; S A Kieffer; L DiGianni; K J Kalkbrenner; J I Bromberg; L A Basili; K Calzone; J Stopfer; B L Weber; J E Garber
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

Review 2.  Genetic testing for inherited breast cancer risk in African Americans.

Authors:  Chanita Hughes Halbert; Lisa Jay Kessler; Edith Mitchell
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

3.  Quality of life after bilateral prophylactic mastectomy.

Authors:  Ann M Geiger; Larissa Nekhlyudov; Lisa J Herrinton; Sharon J Rolnick; Sarah M Greene; Carmen N West; Emily L Harris; Joann G Elmore; Andrea Altschuler; In-Liu A Liu; Suzanne W Fletcher; Karen M Emmons
Journal:  Ann Surg Oncol       Date:  2006-11-11       Impact factor: 5.344

4.  Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing.

Authors:  Heidi A Hamann; Tamara J Somers; Ashley W Smith; Sabra S Inslicht; Andrew Baum
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

5.  Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.

Authors:  Marlene H Frost; Jeffrey M Slezak; Nho V Tran; Constance I Williams; Joanne L Johnson; John E Woods; Paul M Petty; John H Donohue; Clive S Grant; Jeff A Sloan; Thomas A Sellers; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2005-10-03       Impact factor: 44.544

Review 6.  Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation.

Authors:  Sara Wainberg; Janice Husted
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

Review 7.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Laurie Hoyt Huffman; Rongwei Fu; Emily L Harris
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

8.  Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.

Authors:  Suzanne M Miller; Pagona Roussi; Mary B Daly; Joanne S Buzaglo; Kerry Sherman; Andrew K Godwin; Andrew Balshem; Margaret E Atchison
Journal:  Health Educ Behav       Date:  2005-10

9.  Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Authors:  Anne Uyei; Susan K Peterson; Julie Erlichman; Kristine Broglio; Sandra Yekell; Kathkeen Schmeler; Karen Lu; Funda Meric-Bernstam; Chris Amos; Louise Strong; Banu Arun
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

10.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Authors:  L C Hartmann; D J Schaid; J E Woods; T P Crotty; J L Myers; P G Arnold; P M Petty; T A Sellers; J L Johnson; S K McDonnell; M H Frost; R B Jenkins
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

View more
  9 in total

1.  Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone-Based Peer Support Intervention.

Authors:  D St-Pierre; K Bouchard; L Gauthier; J Chiquette; Michel Dorval
Journal:  J Genet Couns       Date:  2017-09-15       Impact factor: 2.537

2.  The effect of peer-led education on the life quality of mastectomy patients referred to breast cancer-clinics in Shiraz, Iran 2009.

Authors:  Farkhondeh Sharif; Narjes Abshorshori; Sedigheh Tahmasebi; Maryam Hazrati; Najaf Zare; Sarah Masoumi
Journal:  Health Qual Life Outcomes       Date:  2010-07-23       Impact factor: 3.186

3.  The evolution of personalized cancer genetic counseling in the era of personalized medicine.

Authors:  Hetal S Vig; Catharine Wang
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 4.  Outcomes of support groups for carriers of BRCA 1/2 pathogenic variants and their relatives: a systematic review.

Authors:  Benedetta Bertonazzi; Daniela Turchetti; Lea Godino
Journal:  Eur J Hum Genet       Date:  2022-01-26       Impact factor: 4.246

5.  Experience of Norwegian Female BRCA1 and BRCA2 Mutation-Carrying Participants in Educational Support Groups: a Qualitative Study.

Authors:  Marion Myklebust; Eva Gjengedal; Nina Strømsvik
Journal:  J Genet Couns       Date:  2016-04-19       Impact factor: 2.537

6.  Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.

Authors:  Patricia A Parker; Susan K Peterson; Yu Shen; Isabelle Bedrosian; Dalliah M Black; Alastair M Thompson; Jonathan C Nelson; Sarah M DeSnyder; Robert L Cook; Kelly K Hunt; Robert J Volk; Scott B Cantor; Wenli Dong; Abenaa M Brewster
Journal:  J Clin Oncol       Date:  2018-07-25       Impact factor: 44.544

Review 7.  Risk-reducing mastectomy for the prevention of primary breast cancer.

Authors:  Nora E Carbine; Liz Lostumbo; Judi Wallace; Henry Ko
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

8.  Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers.

Authors:  Rachael Glassey; Christobel Saunders; Sarah J Hardcastle
Journal:  Front Psychol       Date:  2017-01-31

9.  Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy.

Authors:  Murly B M Tan; Eveline M A Bleiker; Marian B E Menke-Pluymers; Arthur R Van Gool; Silvia van Dooren; Bert N Van Geel; Madeleine M A Tilanus-Linthorst; Karina C M Bartels; Jan G M Klijn; Cecile T M Brekelmans; Caroline Seynaeve
Journal:  Hered Cancer Clin Pract       Date:  2009-03-31       Impact factor: 2.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.